As the second-largest metropolitan area in the United States, Los Angeles has emerged as a critical hub for biotechnology and life sciences. From the burgeoning "Silicon Beach" to the established research clusters in Thousand Oaks and Pasadena, L.A. is redefining how clinical research is conducted. The shift toward Decentralized Clinical Trials (DCTs) is not just a trend; it is a strategic necessity to reach the diverse, sprawling population of Southern California.
By leveraging remote monitoring, wearable biosensors, and digital health platforms, researchers in Los Angeles can overcome geographic barriers, increasing participant diversity and retention. Our solutions provide the technological backbone for this transition, ensuring that data integrity meets the rigorous standards of both the FDA and the local innovation ecosystem.
Los Angeles hosts world-class institutions like UCLA, USC, and Cedars-Sinai. Our DCT solutions integrate seamlessly with these local clinical infrastructures, providing real-time data flow from patient homes directly to research centers.
We provide the IoT-enabled devices and "Clean-Room" certified diagnostic reagents required to maintain the high-tech laboratory standards prevalent in the L.A. bio-corridor.
Our tools are designed for the L.A. lifestyle—mobile-first, intuitive, and supportive of remote participation to reduce the burden of commuting in heavy traffic.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, and healthcare institutions worldwide.
Our product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, and digital research tools. These solutions facilitate real-time data collection, improve participant engagement, and enhance operational efficiency throughout the clinical research process.
Utilizing machine learning to identify eligible participants across Los Angeles's diverse demographics, ensuring equitable representation in clinical studies.
Implementing decentralized ledgers to secure patient data, ensuring that "Source Data" remains immutable and audit-ready for FDA inspections.
Moving beyond simple step-counting to medical-grade ECG, SpO2, and glucose monitoring integrated directly into the DCT platform.
"The future of clinical trials in Los Angeles lies in the 'Virtual Site'—where the clinic comes to the patient, rather than the patient going to the clinic."
In an era of global uncertainty, Supply Chain Resilience is the cornerstone of successful clinical research. Our Dongguan facility operates under Industry 4.0 principles, utilizing automated assembly, real-time inventory tracking, and rigorous AI-based quality inspections.
Clinical trials in California must navigate a complex regulatory landscape, including HIPAA, FDA 21 CFR Part 11, and the California Consumer Privacy Act (CCPA). Our decentralized solutions are built with "Privacy by Design."
DCTs utilize direct-to-digital data capture, which eliminates manual transcription errors. Real-time monitoring allows for immediate detection of adverse events or protocol deviations, enhancing the overall safety and reliability of the study.
Yes, our platforms are designed with HL7 and FHIR standards in mind, allowing for secure API integrations with most major HIS and Electronic Health Record (EHR) systems used by Southern California healthcare providers.
Depending on complexity, initial prototypes are typically ready within 4-8 weeks. Our Dongguan facility's high-capacity production lines ensure that once a design is finalized, mass production and export to Los Angeles can be scaled rapidly.
We employ end-to-end encryption, multi-factor authentication, and anonymized data processing. All systems are compliant with CCPA and HIPAA to protect the Sensitive Personal Information (SPI) of Los Angeles participants.
Contact our growth team today to discuss your specific requirements for decentralized solutions, medical device manufacturing, or laboratory reagents.
Trial Medical
